Clinical Trials in Dothan, Alabama

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT ID: NCT06215716

This clinical trial is studying a medication called efruxifermin (EFX) to see if it can help people with non-cirrhotic Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steato...

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

NCT ID: NCT06548542

This clinical trial is exploring new targeted therapies to treat adults with moderate to severe Crohn's Disease, a long-lasting condition that causes inflammation in the digestive tract and can lea...

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

NCT ID: NCT06880744

This clinical trial is looking at how well a medication called risankizumab works compared to another medication called vedolizumab in treating adults with moderate to severe ulcerative colitis (UC...

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

NCT ID: NCT06052267

This clinical trial is studying whether a new combination inhaler, which includes fluticasone propionate and albuterol sulfate, can help prevent severe asthma attacks better than using albuterol al...

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT ID: NCT06430801

This clinical trial is studying a new medication called tulisokibart, which is being tested for its effectiveness and safety in treating people with moderate to severe Crohn's disease. Crohn's dise...

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT ID: NCT07037459

This clinical trial is studying a medicine called maridebart cafraglutide to see if it can help people who have heart failure with either preserved or mildly reduced heart function, and who are als...

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

NCT ID: NCT06819878

This clinical trial is studying a new treatment called RO7790121 for people with moderately to severely active Crohn's disease, a condition that causes inflammation in the digestive tract. The tria...

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

NCT ID: NCT06672016

This clinical trial is studying a new contraceptive patch that contains a hormone called progestin, which is designed to help prevent pregnancy. The main goals of the study are to evaluate how safe...

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

NCT ID: NCT05769153

This clinical trial is investigating a new treatment called AR-14034 for patients with neovascular age-related macular degeneration (nAMD), a condition that can lead to vision loss. The main goal o...

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

NCT ID: NCT06605599

This clinical trial is studying a new medication called ABBV-932 to see how safe and effective it is for adults with Bipolar I or II Disorder, particularly during depressive episodes. Bipolar disor...

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

NCT ID: NCT07082816

This clinical trial is testing a new eye drop called Reformulated PG324 to see if it can safely and effectively lower eye pressure in people who have open-angle glaucoma or ocular hypertension. The...

A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis

NCT ID: NCT06598462

This clinical trial is investigating a new treatment called NSI-8226 for adults with eosinophilic esophagitis (EoE), a condition where the esophagus (the tube that carries food to your stomach) bec...

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

NCT ID: NCT03891446

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

NCT ID: NCT05563220

This clinical trial is studying a new medication called elacestrant, which is being tested in combination with other treatments for patients with advanced or metastatic breast cancer that is positi...

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

NCT ID: NCT05595642

This clinical trial is studying a new medication called astegolimab to see how well it works and how safe it is for people with Chronic Obstructive Pulmonary Disease (COPD). This study is specifica...

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT ID: NCT05878769

**Study Summary: Astegolimab for COPD** This clinical trial is investigating the long-term safety and effectiveness of a medication called astegolimab in people with Chronic Obstructive Pulmonary ...

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT ID: NCT06095128

This clinical trial is studying the combined effect of two medications, vedolizumab and tofacitinib, in adults with moderate to severe ulcerative colitis (UC). The goal is to see how well this comb...

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

NCT ID: NCT04987229

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

NCT ID: NCT05303064

This clinical trial is studying how a new treatment, OLZ/SAM, affects weight gain in young people with schizophrenia or bipolar I disorder compared to a standard medication called olanzapine. The r...